← Back to browse
HR 747 Passed a chamber

Expands U.S. sanctions authority to cover Chinese companies and officials who enable illicit fentanyl trafficking, while barring sanctions on imported goods under this Act.

Official title: Stop Chinese Fentanyl Act of 2025

Next stop Senate: awaiting action
Timeline each lane is a chamber; dates pull from congress.gov actions
House
Introduced 28-JAN-2025
Referred 28-JAN-2025
Approved by committee 05-MAR-2025
Reported 21-MAR-2025
Passed 02-SEP-2025
Senate
Received 03-SEP-2025
Key points
  • Expands the Fentanyl Sanctions Act definition of foreign opioid trafficker to include Chinese entities that fail to prevent opioid trafficking and Chinese officials who aid it through intentional inaction.
  • Requires the President to report whether the heads of four named Chinese agencies are foreign opioid traffickers, and changes a 5-year period in the identification process to 10 years.
  • Requires annual written evaluations of international drug trafficking emergencies and adds cost-benefit analysis and termination criteria to related regulations under the International Emergency Economic Powers Act.
  • States a nonbinding sense of Congress that China should tighten precursor chemical controls, and bars sanctions on the importation of goods.
AI-generated from the Referred in Senate text of 03-SEP-2025 · verify · report an error
Official CRS summary

Covers an older version. The newest CRS summary describes the bill as of "Introduced in House" (28-JAN-2025); the text has changed since (Engrossed in House, 02-SEP-2025).

CRS is the Library of Congress's nonpartisan research office. Read it on congress.gov
Committee referrals (5) Policy area

International Affairs

Sponsor Andy Barr (R-KY) Cosponsors · 9
■ 7 R■ 2 D